Acapella vs Flutter Devices for Improving Breathing and Lung Function After Lobectomy (NCT07737093) | Clinical Trial Compass
RecruitingNot Applicable
Acapella vs Flutter Devices for Improving Breathing and Lung Function After Lobectomy
Pakistan28 participantsStarted 2026-06-20
Plain-language summary
Lobectomy patients frequently experience postoperative respiratory complications such as secretion retention, dyspnea, impaired gas exchange, and reduced lung function, which can delay recovery. Oscillatory Positive Expiratory Pressure (OPEP) devices such as Acapella and Flutter are commonly used to improve airway clearance and pulmonary function. This study aims to compare the effects of Acapella and Flutter devices on secretion clearance, dyspnea, arterial blood gases, and lung function in post-lobectomy patients.
Who can participate
Age range
35 Years – 54 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients aged 35 to 54 years
* Both male and female patients
* Patients who have undergone lobectomy surgery
* Hemodynamically stable patients
* Patients with adequate respiratory function (able to maintain oxygenation)
* Patients 48 hours post-surgery
* Patients who provide written informed consent to participate in the study
Exclusion Criteria:
* Hemodynamically unstable patients
* Patients within less than 48 hours post-surgery
* Presence of pneumothorax or air leak complications
* Patients with recent major trauma or additional surgery
* Patients with unstable cardiac conditions
* Patients with massive hemoptysis
* Patients unable to cooperate or perform breathing exercises with devices
* Any contraindication to airway clearance techniques as judged by the clinician
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Dyspnea Score
Timeframe: Postoperative Day 1, Postoperative Day 3, and Postoperative Day 5
2
Forced Expiratory Volume in One Second (FEV₁)
Timeframe: Postoperative Day 1, Postoperative Day 3, and Postoperative Day 5
3
Forced Vital Capacity (FVC)
Timeframe: Postoperative Day 1, Postoperative Day 3, and Postoperative Day 5
4
FEV₁/FVC Ratio
Timeframe: Postoperative Day 1, Postoperative Day 3, and Postoperative Day 5